In 2024, the global oral proteins and peptides market was valued at USD 1.8 billion, and it is projected by IMARC Group to rise to USD 3.4 billion by 2033, growing at a 7.13% CAGR from 2025 to 2033. North America led the market, capturing over 97.8% of the share. This growth is driven by technological progress in drug delivery and the demand for non-invasive therapies. Contributing fa... https://www.imarcgroup.com/oral-proteins-peptides-market